1-4 of 4
Karin Fijnvandraat
Close
Sort by
Journal Articles

Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease

Ferdows Atiq, Jessica Heijdra, Fleur Snijders, Johan Boender, Eva Kempers, Waander L. van Heerde, Dominique P. M. S. M. Maas, Sandy Krouwel, Selene C. Schoormans, Joke de Meris, Saskia E. M. Schols, Karin P. M. van Galen, Johanna G. van der Bom, Marjon H. Cnossen, Karina Meijer, Karin Fijnvandraat, Jeroen Eikenboom, Frank W. G. Leebeek
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5317–5326.
https://doi.org/10.1182/bloodadvances.2021006757
Published: 2022
Includes: Supplemental data
Journal Articles

The bleeding phenotype in people with nonsevere hemophilia

Fabienne R. Kloosterman, Anne-Fleur Zwagemaker, Catherine N. Bagot, Erik A. M. Beckers, Giancarlo Castaman, Marjon H. Cnossen, Peter W. Collins, Charles Hay, Michel Hof, Britta Laros-van Gorkom, Frank W. G. Leebeek, Christoph Male, Karina Meijer, Ingrid Pabinger, Susan Shapiro, Michiel Coppens, Karin Fijnvandraat, Samantha C. Gouw,
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4256–4265.
https://doi.org/10.1182/bloodadvances.2022007620
Published: 2022
Includes: Supplemental data
Journal Articles

Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease

Laura H. Bukkems, Jessica M. Heijdra, Nico C. B. de Jager, Hendrika C. A. M. Hazendonk, Karin Fijnvandraat, Karina Meijer, Jeroen C. J. Eikenboom, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Marjon H. Cnossen, Ron A. A. Mathôt
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1513–1522.
https://doi.org/10.1182/bloodadvances.2020003891
Published: 2021
Includes: Supplemental data
Journal Articles

Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review

Clinical Trials & Observations
Joep W. R. Sins, David J. Mager, Shyrin C. A. T. Davis, Bart J. Biemond, Karin Fijnvandraat
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1598–1616.
https://doi.org/10.1182/bloodadvances.2017007211
Published: 2017
Includes: Supplemental data